UUID: 95%AADBIE— —77C9- A721— 5624- F9CCF049575eF
- B7—A3M -9 91-A PR 1

I111111T1116111111111111111111111111111111111111111111111111iil|11Ed

1111 1111111111111111111|1||1 11111111111
| iiliililiiiil1111111111111111|1111111111||1|11111|1| %
Clinical Case Report

”5-0 3 (For Collection of Cancerous Tissue)

Wm [WMp’ ”bull/U; Mg 8590’} Cliterll
Stink WAN; C50 q . HIPAA

”5171»
Informed Consent!

I personally informed this patient that a specimen(s) would be collected to be used for research
purposes. I reviewed the 1 RESEARCH SUBJECT INFORMATION AND CONSENT
FORM with the patient and answered any questions the patient had. The patient then signed the
consent form as a free and voluntary act. A copy of this informed consent document will be retained at
our institution.

 

‘lumur

 

Name of Physician or Study Coordinator Signature Date

 

 

[Clinical Information]

- , RMA'HO . .1 . .
Of Birth ( Rafa
:1 Single Married
Gender 1:] Divorced 1:! Widow Blood Pressure

D Male emale

 

 

W 1 ramSTORYOFPRESENTILLNESS“
ChIef Complaints: TWA/WV v5 law (11% Mt

Symptoms= p41“; W {W 19th 51(11th ‘n 2W.

i‘iykcajr {2.4M Qxd’G‘rtW
va iuvv 1‘ i1: 1’9an Sim,» .

 

 

 

Clinical Findings:«\

Lu. Leta, Wye/u mien, qu

 

§Performance Scale (Kamofsky Score):
i u 100 Asymptomatic a 80-90 Symptomatic but Fully Ambulatory
‘ [1 40-50 Symptomatic, in bed more than 50% of day. but not bed ridden

1:! 60-70 Symptomatic, in bed less than 50% of day
El 20—30 Bed Ridden

 

 

 

Route

 

PAST= MEDICAL HISTORY; ’ m , -' ‘
Disorder Treatment Status

 

 

        
   
   

 

 

 

 

 

 

 

I tiiQEiiOBZGYN HISTOR' . ..
Menopausal Status Date of First Menses # of Mancies
1:1 Pro-menopausal W r-U‘ .-
Eyed-Menopausal Date of Last Menses # of Live Births
Post-menopausal W Va .
Birth Control: :1 Condom D Oral Contraceptive :1 ND 13 Hormone Replacement
C! Other: N0 . Therapy:

 

 

 

 

 

 

R
Environmental

Smoki l-l
Current Duration
El YES

Alcohol Consum
Duration

Use
Duration

Relative

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

VLAB DATA
Test Result Date f Test Result
HIV b/Negative D Positive: : ". CEA O Negative 13 Positive:

Hep B [iii/Negative E1 Positive: CA 15-3 1:1 Negative El Positive:
Hep C 12 Negative :1 Positive: ' CA 19-9 0 we [:1 Positive:
AF P 13 Negative :1 Positive: PSA :1 Negative 1:] Positive:
' ' - Other: . . .
Other. Cl Negative El Positive: 1:1 Negative D POSIIIVCI“
BIT Cell Markers:

 

 

 

, Q ‘ifiié'rDIAGNOSTIC STUDIES-5:23;:
Results

Ultrasound
x-
CT

' .. CLINICAL DIA
Clinical
t .

Involved L Nodes Location of

Clinical
N M Stage:

 

[Treatment Information!

' IG'AL:
Procedure

Tumor
Detailed Location

9

Extension of

L Nodes
Location of L Nodes
Palpable, Nun-Dissected Lymph Nodes
Dissected Lymph Nodes

Distant Metastasis
Detailed Location

i . ‘NEO'
Treatment

 

Date of Procedure

Size
x

 

Collected by:

Preserved by:

i‘uw E ,

Frozen
Diseased Normal

Time to LN2

Pathology Form

 

Epecimen Information]

 

Date: . Time:
Date _ . «Time:

, E #, .1
Parafﬁn Block m/Plasma
Diseased

Slide

Normal Normal Diseased Normal

)4

Time to Formalin to LNZ
min

B. 7 ' GEOGI D
Prima Tumor
Size Extension of Tumor Distance to NAT
\

‘S-X“ X cm Z, cm

Nodes
# Examined # Metastasized

8

9-—

Distant Metastasis
Detailed Location v

 

CONSOLIDATED DIAGNOSTIC PATHOLOGY FORM* '

“m""m’l’it Appearance

1.

CELL msmmtmon

Diﬂ‘use
Mosaic

L

 

 

Clusteriud
File
Cellular
4- -
Cell “i: .1” Cell Stratiﬁcation
Secretion
Desmosome acuole
Pearl Gland formation
Speciﬁed:
7 DD
2. Cdlularniﬂ‘emﬁarlon:
Well Moderately ’12“:

 

 

 

 

 

 

  

3. Nuclear

 

 

Nuclear
“ ' W 6' 3
mstological nemesismzmmgﬁizzbm—Cﬂwj
Comments:
f—Txrf’

Director. KW

.mo
5100mm
.(mﬁcurro REPORT or FINDINGS

